Pre-treatment with hydration and electrolytes may prevent dose limiting toxicities during foscarnet induction therapy.
Jayaweera
D
D
White
G
G
Moreno
J
J
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D004573:Electrolytes / Q000627:therapeutic use; D017245:Foscarnet / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D011292:Premedication; D011446:Prospective Studies; D014867:Water / Q000008:administration & dosage; D014883:Water-Electrolyte Imbalance / Q000517:prevention & control*
D000998:Antiviral Agents; D004573:Electrolytes; D014867:Water; D017245:Foscarnet